Literature DB >> 2958495

Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis.

A Durandy1, A Fischer, F Le Deist, E Drouhet, C Griscelli.   

Abstract

We have studied T- and B-cell responses to antigens of Candida albicans in 18 patients suffering from chronic mucocutaneous candidiasis. We have shown that in vitro production of antibody to one of these antigens, mannan, was absent during the active phase of the disease and that this absence was consequent to the activation of specific CD8(+) and CD8(-) suppressor T lymphocytes. Such activation was also observed when control T lymphocytes were incubated in the presence of monocytes and a high concentration of mannan. This suppressive effect was specific to antigens of Candida albicans, was radiosensitive, and was not consequent to the secretion of prostaglandin E2. It appeared as well that the induction of these suppressor T cells was HLA-DQ restricted. The suppressor T-cell activity induced by antigens of Candida albicans in vitro is thus comparable to the suppressor T-cell activity observed in vivo in patients affected with chronic mucocutaneous candidiasis. Defective handling of mannan by monocytes could result in the accumulation of mannan, resulting in the activation of specific T suppressor cells and in the consequent cellular immunodeficiency specific to Candida albicans. Successful treatment of the candidiasis resulted in complete correction of the immune abnormalities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958495     DOI: 10.1007/bf00917018

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  34 in total

1.  Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy.

Authors:  C H Kirkpatrick; T K Smith
Journal:  Ann Intern Med       Date:  1974-03       Impact factor: 25.391

2.  Functional analysis of human T cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset.

Authors:  Y Thomas; L Rogozinski; O H Irigoyen; H H Shen; M A Talle; G Goldstein; L Chess
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

3.  Responses of human peripheral lymphocytes to soluble and insoluble antigens of Candida albicans.

Authors:  S M Gettner; D W Mackenzie
Journal:  J Med Microbiol       Date:  1981-08       Impact factor: 2.472

4.  Characterization of HLA-D-region antigens by two-dimensional gel electrophoresis. Molecular-genotyping.

Authors:  D J Charron; H O McDevitt
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

5.  Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.

Authors:  P Y Paterson; R Semo; G Blumenschein; J Swelstad
Journal:  Clin Exp Immunol       Date:  1971-11       Impact factor: 4.330

6.  A non-specific inhibitor produced by Candida albicans activated T cells impairs cell proliferation by inhibiting interleukin-1 production.

Authors:  G Lombardi; D Vismara; E Piccolella; V Colizzi; G L Asherson
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

7.  Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.

Authors:  E Drouhet; B Dupont
Journal:  Am J Med       Date:  1983-01-24       Impact factor: 4.965

8.  Suppressor cells induced by BCG release non-specific factors in vitro which inhibit DNA synthesis and interleukin-2 production.

Authors:  V Colizzi; J Ferluga; F Garreau; M Malkovsky; G L Asherson
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

9.  Human B cell differentiation. IV. Effect of monoclonal anti-immunoglobulin M and D antibodies on B cell proliferation and differentiation induced by T cell factors.

Authors:  T Kuritani; M D Cooper
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

10.  Purification and characterization of a mannose-containing disaccharide obtained from human pregnancy urine. A new immunoregulatory saccharide.

Authors:  A V Muchmore; J M Decker; R M Blaese; B Nilsson
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Fungal skin infections.

Authors:  R J Hay
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

2.  Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.

Authors:  M J Gomez; A Torosantucci; S Arancia; B Maras; L Parisi; A Cassone
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis.

Authors:  C H Little; G M Georgiou; A Marceglia; H Ogedgebe; R E Cone; D Mazza
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.

Authors:  A Mencacci; A Torosantucci; R Spaccapelo; L Romani; F Bistoni; A Cassone
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

Review 7.  Cutaneous defenses against dermatophytes and yeasts.

Authors:  D K Wagner; P G Sohnle
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

8.  Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as beta-1,2-linked oligomannosyl residues.

Authors:  N Shibata; M Arai; E Haga; T Kikuchi; M Najima; T Satoh; H Kobayashi; S Suzuki
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Expression of the C3d-binding protein (CR2) from Candida albicans during experimental candidiasis as measured by lymphoblastogenesis.

Authors:  M Fukayama; E Wadsworth; R Calderone
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.